Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • Rights and Permissions
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • Rights and Permissions
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Eosinophils Maintain Their Capacity to Signal and Release Eosinophil Cationic Protein Upon Repetitive Stimulation with the Same Agonist

Hans-Uwe Simon, Martina Weber, Eva Becker, Yael Zilberman, Kurt Blaser and Francesca Levi-Schaffer
J Immunol October 1, 2000, 165 (7) 4069-4075; DOI: https://doi.org/10.4049/jimmunol.165.7.4069
Hans-Uwe Simon
Swiss Institute of Allergy and Asthma Research, University of Zurich,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martina Weber
Swiss Institute of Allergy and Asthma Research, University of Zurich,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva Becker
Clinic for Dermatology and Allergy (Alexanderhausklinik), Davos, Switzerland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yael Zilberman
Department of Pharmacology, School of Pharmacy, The Hebrew University-Hadassah Medical School, Jerusalem, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kurt Blaser
Swiss Institute of Allergy and Asthma Research, University of Zurich,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesca Levi-Schaffer
Department of Pharmacology, School of Pharmacy, The Hebrew University-Hadassah Medical School, Jerusalem, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    ECP mRNA levels in blood eosinophils of control individuals and patients with eosinophilia. A, Blood was obtained from atopic dermatitis patients (AD) and control individuals (N). mRNA was evaluated by RT-PCR. G3PDH served as control. B, The ECP content in blood eosinophils of normal controls (N, n = 4), patients with atopic dermatitis (AD, n = 15) or the hypereosinophilic syndrome (HES, n = 2). Data are mean ± SEM.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    ECP is released after priming with GM-CSF and subsequent stimulation with PAF or C5a, but not eotaxin. Data presented as mean ± SEM. The numbers of independent experiments for each condition varied between two and six (∗, p < 0.05).

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Release of ECP from eosinophils upon repeated stimulation. GM-CSF-primed eosinophils were stimulated with either PAF or with C5a twice. Time periods between stimulations included a washing step and varied from 0 to 30 min (PAF) and from 0 to 80 min (C5a). No significant ECP releases upon second stimulation were observed within these time periods without a washing step after the first stimulation (ECP concentrations always <15 μg/L). Results of one representative of five independent experiments is shown in each case.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Intracellular calcium changes in eosinophils in response to repeated stimulation with PAF or with C5a. Calcium signals were measured by fura-2 fluorescence. A, Arrows indicate the time point of addition of the agonists. The cells were not washed between the stimulations. One representative of five independent experiments is shown in each case. B, Calcium signals upon repeated stimulation. The cells were washed between the applications of the agonists. “0” represents freshly purified cells that had been stimulated with the indicated agonists for the first time. The time interval (5 and 15 min) between the applications is indicated and includes the washing step. Five minutes after the first stimulation, a second PAF stimulation was associated with rapid calcium response, which was only slightly less compared with the first response. In contrast, complete homologous desensitization was observed in the case of C5a, because the second C5a stimulation did not result in an increase of intracellular free calcium levels at this time point. Results of one representative of five (C5a) or six (PAF) independent experiments is shown.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Expression of PAF receptors on eosinophils. A, Flow cytometry. Cells were incubated without (upper left) or with (upper middle and right) the fluorescent PAF agonist, at 4° or 37°C as indicated. The cells were then washed and analyzed again by FACS (lower left and middle). The results indicate that the washing procedure fully removed the PAF agonist from cells incubated at 4°C but not at 37°C. Reapplication of the fluorescent probe (lower right) indicates the availability of receptors following the washing procedure. The number at the upper right corner of each histogram indicates the ratio calculated as the mean channel fluorescence level following PAF staining divided by the mean channel fluorescence level obtained from unstained eosinophils. In the presence of WEB 2086 (1 mM), fluorescent PAF binding was blocked (ratio: 0.96). Results are representative of three independent experiments. B, Fluorescent microscopy. Fluorescent lyso-PAF bound to eosinophil membrane. Washing removed the fluorescent ring signal. A second incubation with fluorescent lyso-PAF resulted again in a ring-like staining of the eosinophils, suggesting the availability of free PAF receptors. Similar results were obtained using fluorescent PAF, although the fluorescent signal was slightly decreased compared with lyso-PAF. Results are representative of three independent experiments.

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    The effect of GM-CSF on ECP mRNA in control eosinophils (A) or following partial depletion of ECP levels due to concomitant stimulation with both PAF and C5a (B). G3PDH served as control. Results are representative of three independent experiments.

  • FIGURE 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 7.

    The effect of GM-CSF on ECP protein expression in eosinophils with decreased ECP levels. Eosinophils were simultaneously three times stimulated with optimal concentrations of PAF and C5a within 6 h. The following percentages of the original ECP content were observed in the five presented independent experiments: 1, 76%; 2, 52%; 3, 30%; 4, 53%; and 5, 40%. The viability of the eosinophil populations after the releases was 80–95%. Eosinophils were washed and cultured in the presence and absence of GM-CSF for 14 h and total ECP contents determined.

  • FIGURE 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 8.

    Expression of ECP in eosinophilic tissues. ECP expression was determined in the indicated tissues by immunohistochemistry using an anti-ECP mAb (magnification, ×400 to ×1000). Except bladder and bone (one experiment in each case), similar results were obtained in at least three more independent experiments using nasal mucosa, skin, stomach, and intestine eosinophilic tissues.

Tables

  • Figures
    • View popup
    Table I.

    Repetitive PAF-induced ECP release (micrograms per liter) from GM-CSF primed eosinophilsa

    Expt.Stimulation
    123456
    1739567119NDND
    2110160133986742
    33415317693159ND
    430010917614780ND
    52171171331228253
    625311169876949
    • a GM-CSF-primed eosinophils were repeatedly stimulated with PAF and ECP levels measured in the supernatants. Cells were washed after each release. The time period between the stimulations was 1 h. Control stimulations with GM-CSF alone were performed in each case and revealed ECP concentrations of <15 μg/L. Six independent experiments are shown.

    • View popup
    Table II.

    Total ECP content (micrograms per liter) does not increase in eosinophils cultured with GM-CSFa

    Expt.Freshly PurifiedMedium (4 h)GM-CSF (4 h)Medium (8 h)GM-CSF (8 h)Medium (20 h)GM-CSF (20 h)
    11623191017501962188619681816
    22110216020002120204021201906
    32410274028602800290028602760
    • a Eosinophils were cultured in the absence or presence of GM-CSF for the indicated times. Total ECP content was determined in Triton X-100-treated eosinophils (106/ml). Three independent experiments are shown.

PreviousNext
Back to top

In this issue

The Journal of Immunology: 165 (7)
The Journal of Immunology
Vol. 165, Issue 7
1 Oct 2000
  • Table of Contents
  • About the Cover
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Eosinophils Maintain Their Capacity to Signal and Release Eosinophil Cationic Protein Upon Repetitive Stimulation with the Same Agonist
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
Citation Tools
Eosinophils Maintain Their Capacity to Signal and Release Eosinophil Cationic Protein Upon Repetitive Stimulation with the Same Agonist
Hans-Uwe Simon, Martina Weber, Eva Becker, Yael Zilberman, Kurt Blaser, Francesca Levi-Schaffer
The Journal of Immunology October 1, 2000, 165 (7) 4069-4075; DOI: 10.4049/jimmunol.165.7.4069

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Eosinophils Maintain Their Capacity to Signal and Release Eosinophil Cationic Protein Upon Repetitive Stimulation with the Same Agonist
Hans-Uwe Simon, Martina Weber, Eva Becker, Yael Zilberman, Kurt Blaser, Francesca Levi-Schaffer
The Journal of Immunology October 1, 2000, 165 (7) 4069-4075; DOI: 10.4049/jimmunol.165.7.4069
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Suppression of inflammation in collagen-induced arthritis by administration of recombinant Fcγ receptors (54.17)
  • The immunological ménage à trois promotes inflammation in Type 2 diabetes. (54.14)
  • Identification of novel small molecule inducers of endothelium-driven innate immunity (54.10)
Show more INFLAMMATION

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2019 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606